Kanghua Biotech (002022.SZ) has obtained a registration certificate for a medical device product.

Zhixun Finance APP News, Kehua Bio (002022.SZ) announced that the company recently received a medical device registration certificate (in vitro diagnostic reagent) issued by the Shanghai Food and Drug Administration. The product involved is the ferritin assay kit (latex immunoturbidimetry). This assay kit is used by medical institutions for the quantitative determination of ferritin (FER) in human serum and plasma samples. It is mainly used in clinical settings for the auxiliary diagnosis of diseases related to iron metabolism, such as hemosiderosis and iron-deficiency anemia.